Nature Research Cancer Community
Contributor Nature Comms
To wait for resistance to drugs to develop in patients and then identify why it happened, will lead to a deadly lag in the design of salvage therapies or indeed preventative treatment approaches.
Contributor Nature Genetics
In our latest manuscript we describe a systematic analysis of negative selection pressures acting on neoantigen forming mutations. Contrary to what is generally believed we did not find any clear evidence of this immunogenic form of selection and the resulting neoantigen depletion.
Contributor Nature Cancer
Turns out there are times when it’s important to improve on mother nature, especially when confronting a life-threatening disease.
Contributor Nature Medicine
Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.
In the November issue of Nature Medicine we describe the development of a first-in-class inhibitor of CLCF1 signaling and its effectiveness in several precllinical models of lung adenocarcinoma
Behind the paper
Share the story behind your paper, from conception to publication, the highs and the lows
In the news
Share and discuss the latest news in cancer research
Share your thoughts with the community
A recent article was published in the Minneapolis Star Tribune and it was written by Heidi Stevens, who writes for the Chicago Tribune. This is a very important article for families and individuals whose whole life has been turned upside down because of cancer.
About the community
Updates, guidance and advice on how to get the most from the community